Giant Biogene IPO Lock-Up - US$1.7bn Lockup Release Will Increase Free Float by 14x
Giant Biogene raised around US$70m in its Hong Kong IPO, after having downsized the deal and priced it at the low-end. Its six-month lockup will...
369 Views
Tencent Meituan Dividend - The US$17bn Overhang Is Here - Not All Shares in CCASS, Here We Go Again!
On 16th Nov 22, Tencent declared an interim dividend by way of distribution in specie of Class B Ordinary shares of Meituan. The settlement was...
553 Views
Adani Enterprises US$2.4bn FPO - Updates, Pricing, Structure, Anchor and Some More
Adani Enterprises is looking to raise INR200bn (US$2.4bn) via a further public offering (FPO). We have covered most of the details in our prior...
595 Views
Aequitas 2022 IPOs and Placements Performance Review - From the Busiest Year to the Slowest Year
2022 marked our seventh year covering Equity Capital Markets (ECM) in Asia Pacific. 2022 was rather quiet ending with us covering one of the lowest...
450 Views
China Semiconductor Restrictions: How the Vice Is Becoming Tighter and Tighter
Recent developments show the U.S. has motivated additional countries to participate and more restrictions are likely in 2023E.
649 Views